Brief: Sab Biotherapeutics Advancing Pipeline And Expands Into Treatment For C. Diff. As Dod Contract Winds Down

SAB Biotherapeutics

09/08/2022 23:32

Aug 9 (Reuters) - SAB Biotherapeutics Inc  SABS.O :
    * SAB BIOTHERAPEUTICS ADVANCING PIPELINE AND EXPANDS INTO
TREATMENT FOR C. DIFF. AS DOD CONTRACT WINDS DOWN
    * SAB BIOTHERAPEUTICS - CO AND DOD WILL ENGAGE IN
NEGOTIATION TO
ADDRESS ALL OPEN ITEMS UNDER DEAL, EXPECTED TO INCLUDE
MULTI-MILLION-DOLLAR PAYMENT TO CO

Source text for Eikon:  ID:nGNX85xKv0 
Further company coverage:  SABS.O 

 ((Reuters.Briefs@thomsonreuters.com;))